The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Cited by (1,019)

Items 901–1,000 of 1,019

1. SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia
   Cuijuan Han, Alireza Khodadadi‐Jamayran, Adam H. Lorch, Qi Jin, Valentina Serafin, Ping Zhu, Yuliya Politanska, Limin Sun, Blanca T. Gutierrez-Diaz, Marina V. Pryzhkova et al. · 2022 · Science Advances
2. Optical Genome Mapping for Cytogenetic Diagnostics in AML
   Verena Nilius‐Eliliwi, Wanda Maria Gerding, Roland Schroers, Huu Phuc Nguyen, Deepak Vangala · 2023 · Cancers
3. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
   Jian‐Gang Ren, Bowen Xing, Kaosheng Lv, Rachel A. O’Keefe, Meng‐Fang Wu, Ruoxing Wang, Kaylyn M. Bauer, Arevik Ghazaryan, George M. Burslem, Jing Zhang et al. · 2023 · Journal of Clinical Investigation
4. METTL1 mediated tRNA m7G modification promotes leukaemogenesis of AML via tRNA regulated translational control
   Pan Zhao, Xia Lin, Dan Chen, Wei Xu, Huanping Guo, Yinying Xu, Bingbing Yan, Xiao Wu, Yuxia Li, Yunfang Zhang et al. · 2024 · Experimental Hematology and Oncology
5. NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
   Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci, Jérôme Rey, Gaëlle Bouvier, Emmanuel Gautherot, Samuel Granjeaud, Clémence Demerle, Jean-François Hamel, Adelheid Cerwenka et al. · 2017 · Oncotarget
6. Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMT
   Reinhold Munker, Myriam Labopin, Jordi Esteve, Christoph Schmid, Mohamad Mohty, Arnon Nagler · 2017 · Haematologica
7. Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance
   Long Su, Yehui Tan, Hai Lin, Xiao‐Liang Liu, Li Yu, Yanping Yang, Shanshan Liu, Ou Bai, Yang Yan, Fengyan Jin et al. · 2018 · Oncotarget
8. Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
   María Julia Montoro, Laura Gallur, Brayan Merchán, Antonieta Molero, Elisa Roldán, Fernando Martínez‐Valle, Guillermo Javierre Villacampa, Mayda Navarrete, Margarita Ortega, Josep Castellví et al. · 2018 · Annals of Hematology
9. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update
   Adrián Montaño, Maribel Forero‐Castro, Darnel Marchena-Mendoza, Rocí­o Benito, Jesús María Hernández‐Rivas · 2018 · Cancers
10. Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms
    Anna B. Halpern, Megan K. D. Othus, Emily M. Huebner, Bart Lee Scott, Pamela Sue Becker, Mary‐Elizabeth M. Percival, Paul C. Hendrie, Kelda M. Gardner, Tara L. Chen, Sarah A. Buckley et al. · 2018 · Leukemia
11. Advances in treatment formulations for acute myeloid leukemia
    Thomas Briot, Emilie Roger, Sylvain Thépot, Frédéric Lagarce · 2018 · Drug Discovery Today
12. Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy
    Martin Grießhammer, Parvis Sadjadian, Kai Wille · 2018 · Expert Review of Hematology
13. FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis
    Yvette L. Kasamon, Chia‐Wen Ko, Sriram Subramaniam, Lian Ma, Yuching Yang, Lei Nie, Stacy Shifflett Shord, Donna Przepiorka, Ann T. Farrell, Amy E. McKee et al. · 2018 · The Oncologist
14. Prefibrotic myelofibrosis: treatment algorithm 2018
    Guido Finazzi, Alessandro Maria Vannucchi, Tiziano Barbui · 2018 · Blood Cancer Journal
15. The Misclassification of Diffuse Gliomas: Rates and Outcomes
    Julian Bryan Iorgulescu, Matthew Torre, Maya Harary, Timothy Richard Smith, Ayal Aaron Aizer, David A. Reardon, Jill S. Barnholtz‐Sloan, Arie Perry · 2019 · Clinical Cancer Research
16. The leukemia strikes back: a review of pathogenesis and treatment of secondary AML
    Edna Cheung, Anthony J. Perissinotti, Dale Lee Bixby, Patrick W. Burke, Kristen Marie Pettit, Lydia L. Benitez, Julia M. Brown, Gianni Bruno Scappaticci, Bernard Lawrence Marini · 2019 · Annals of Hematology
17. Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia
    Mohammed Hussein Kamareddine, Youssef Ghosn, Antonios Tawk, Carlos Elia, Walid Alam, Joseph Makdessi, Said G Farhat · 2019 · Technology in Cancer Research & Treatment
18. Megakaryocyte polyploidization: role in platelet production
    William Vainchenker, Hana Raslová · 2019 · Platelets
19. Platelet Dysfunction and Thrombosis in JAK2 V617F -Mutated Primary Myelofibrotic Mice
    Shinobu Matsuura, Cristal Reyna Thompson, Mostafa Belghasem, Roelof Hendrik Bekendam, Andrew J. Piasecki, Orly Leiva, Anjana Ray, Joseph E. Italiano, Moua Yang, Glenn Merrill‐Skoloff et al. · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
20. Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
    Sagarajit Mohanty, Nidhi Jyotsana, Amit Kumar Sharma, Arnold Kloos, Razif R. Gabdoulline, Basem Othman, Courteney K. Lai, Renate Schottmann, Madhvi Mandhania, Johannes Schmoellerl et al. · 2020 · Cancers
21. Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS
    Anna Stengel, Rabia Shahswar, Torsten Haferlach, Wencke Walter, Stephan Hütter, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach · 2020 · Blood Advances
22. Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
    Giuseppe Gaetano Loscocco, Paola Guglielmelli, Alessandro Maria Vannucchi · 2020 · OncoTargets and Therapy
23. Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations
    Naseema Gangat, Ayalew Tefferi · 2020 · American Journal of Hematology
24. Noncanonical immune response to the inhibition of DNA methylation by Staufen1 via stabilization of endogenous retrovirus RNAs
    Yongsuk Ku, Joo‐Hwan Park, Ryeongeun Cho, Yong-Ki Lee, Hyoung-Min Park, Min A Kim, Kyunghoon Hur, Soo Young Byun, Jun Liu, Young-suk Lee et al. · 2021 · Proceedings of the National Academy of Sciences
25. Current Treatment of Juvenile Myelomonocytic Leukemia
    Christina Mayerhofer, Charlotte Marie Niemeyer, Christian Flotho · 2021 · Journal of Clinical Medicine
26. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3
    Yipei Jing, Xueke Jiang, Li Lei, Meixi Peng, Jun Ren, Qiaoling Xiao, Yao Tao, Yonghong Tao, Junpeng Huang, Lu Wang et al. · 2021 · Journal of Experimental & Clinical Cancer Research
27. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis
    Sordi, Benedetta, Vanderwert, Fiorenza, Crupi, Francesca, Gesullo, Francesca, Zanotti, Roberta, Bonadonna, Patrizia, Crosera, Lara, Elena, Chiara, Fiorelli, Nicolas, Ferrari, Jacqueline et al. · 2023 · Journal of Allergy and Clinical Immunology
28. Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
    Haris Ali, Ni‐Chun Tsai, Timothy Walter Synold, Sally Mokhtari, Weimin Tsia, Joycelynne Michelle Palmer, Tracey Stiller, Monzr M. Al Malki, Ibrahim Taha Aldoss, Amandeep Salhotra et al. · 2021 · Blood Advances
29. How I diagnose and treat chronic myelomonocytic leukemia
    Mrinal M. Patnaik · 2022 · Haematologica
30. Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy
    Naveen Pemmaraju, Prithviraj Bose, Raajit K. Rampal, Aaron Thomas Gerds, Angela G. Fleischman, Srđan Verstovšek · 2023 · Leukemia & lymphoma/Leukemia and lymphoma
31. Natural history study of patients with familial platelet disorder with associated myeloid malignancy
    Lea Cunningham, Matthew Merguerian, Katherine R. Calvo, Joie Davis, Natalie T Deuitch, Alina Dulau‐Florea, Nisha Patel, Kai Yu, Keith A. Sacco, Sumona Bhattacharya et al. · 2023 · Blood
32. A PI3K p110β–Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis
    Haluk Yuzugullu, Lukas Baitsch, Thanh Von, Allison Steiner, Haoxuan Tong, Jing Ni, Linda K. Clayton, Roderick Terry Bronson, Thomas M. Roberts, Kira Gritsman et al. · 2015 · Nature Communications
33. Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone
    Hong Tian, Yang Xu, Liming Liu, Lingzhi Yan, Zhengming Jin, Xiaowen Tang, Yue Han, Zhengzheng Fu, Huiying Qiu, Aining Sun et al. · 2016 · Leukemia Research
34. Investigation and Management of Erythrocytosis
    Mary Frances McMullin · 2016 · Current Hematologic Malignancy Reports
35. Acute myeloid leukemia with TP53 germ line mutations
    Armin Zebisch, Ridhima Lal, Marian Müller, KARIN LIND, Karl Kashofer, Michael Girschikofsky, David Fuchs, Albert Wölfler, Jochen B. Geigl, Heinz Sill · 2016 · Blood
36. Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis
    Marco Romano, Daria Sollazzo, Sara Trabanelli, Martina Barone, Nicola Polverelli, Margherita Perricone, Dorian Forte, Simona Luatti, Michèle Cavo, Nicola Vianelli et al. · 2017 · OncoImmunology
37. Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
    Zimu Gong, Leonard Jeffrey Medeiros, Jörge E. Cortes, Zi Chen, Lan Zheng, Yan Li, Shi Bai, Pei Lin, Roberto N. Miranda, Jeffrey L. Jorgensen et al. · 2017 · Blood Advances
38. BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Fernando Vieira Pericole, Mariana Lazarini, Luciana Bueno de Paiva, Adriana Silva Santos Duarte, Karla Priscila Ferro, Fernanda Soares Niemann, Fernanda Marconi Roversi, Sara Teresinha Olalla Saad · 2019 · Frontiers in Oncology
39. Myeloid disorders after autoimmune disease
    Prajwal Chaitanya Boddu, Amer Methqal Zeidan · 2019 · Best Practice & Research Clinical Haematology
40. The Role of New Technologies in Myeloproliferative Neoplasms
    Giuseppe A. Palumbo, Stefania Stella, Maria Stella Pennisi, Cristina Pirosa, Elisa Fermo, Sonia Fabris, Daniele Cattaneo, Alessandra Iurlo · 2019 · Frontiers in Oncology
41. Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
    Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, Andrew A. Lane, John O Mascarenhas · 2019 · Clinical Lymphoma Myeloma & Leukemia
42. Novel approaches to treating advanced systemic mastocytosis
    JA Gilreath, Luba Tchertanov, Michael W. Deininger · 2019 · Clinical Pharmacology Advances and Applications
43. Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
    Susanne Saußele, Wilhelm Haverkamp, Fabian Lang, Steffen Koschmieder, Alexander Kiani, Kathleen Jentsch‐Ullrich, Frank Stegelmann, Heike Pfeifer, Paul Graf La Rosée, Nicola Goekbuget et al. · 2019 · Acta Haematologica
44. How advanced are we in targeting novel subtypes of ALL?
    Charles Grenfell Mullighan · 2019 · Best Practice & Research Clinical Haematology
45. Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia
    Yingyu Chen, Jianda Hu · 2020 · Therapeutic Advances in Hematology
46. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
    Knut Brockow, Katarzyna Plata‐Nazar, Magdalena Lange, Bogusław Nedoszytko, Marek Niedoszytko, Peter Valent · 2021 · International Journal of Molecular Sciences
47. Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
    Aline Renneville, Jessica A. Gasser, Daniel E. Grinshpun, Pierre M. Jean Beltran, Namrata D. Udeshi, Mary E. Matyskiela, Thomas Clayton, Marie E. McConkey, Kaushik Viswanathan, Alexander Tepper et al. · 2021 · Blood Cancer Discovery
48. Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
    Cheng‐Hong Tsai, Jih‐Luh Tang, Feng‐Ming Tien, Yuan‐Yeh Kuo, Dung-Chi Wu, Chien‐Chin Lin, Mei‐Hsuan Tseng, Yen‐Ling Peng, Mei-Fang Hou, Yi‐Kuang Chuang et al. · 2021 · Blood Advances
49. Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
    Niloefar Ahmadi Bidakhvidi, Karolien E. Goffin, Jeroen Dekervel, Kristof Baete, Kristiaan Nackaerts, Paul M. Clément, Eric Van Cutsem, Chris Verslype, Christophe M. Deroose · 2021 · Cancers
50. Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
    Caner Saygin, Gregory W. Roloff, Christopher Norman Hahn, Rakchha Chhetri, Saar I. Gill, Hany Elmariah, Chetasi Talati, Emma Nunley, Guimin Gao, Aelin Kim et al. · 2022 · Blood Advances
51. Mutational landscape of myelodysplastic/myeloproliferative neoplasm–unclassifiable
    Prithviraj Bose, Aziz Nazha, Rami S. Komrokji, Keyur Pravinchandra Patel, Sherry A. Pierce, Najla Al‐Ali, Andrew L. Sochacki, Aaron C. Shaver, Wencai Ma, Xiaoping Su et al. · 2018 · Blood
52. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
    Eulàlia Genescà, Mireia Morgades, Pau Montesinos, Pere Barba, Cristina Gil, Ramón Guàrdia, María‐José Moreno, Daniel Martínez‐Carballeira, Irene García‐Cadenas, Susana Vives et al. · 2019 · Haematologica
53. Definition, Epidemiology, Pathophysiology, and Essential Criteria for Diagnosis of Pediatric Chronic Myeloid Leukemia
    Meinolf Suttorp, Frédéric Millot, Stephanie Sembill, Hélène Deutsch, Markus Metzler · 2021 · Cancers
54. Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond
    Anna Aureli, Beatrice Marziani, Adriano Venditti, Tommaso Sconocchia, Giuseppe Sconocchia · 2023 · Cancers
55. Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms
    Alexandre Guy, Geoffrey Garcia, Virginie Gourdou‐Latyszenok, Laura Wolff-Trombini, Lara Josserand, Quentin Kimmerlin, Simon Favre, Badr Kilani, Caroline Marty, Yacine Boulaftali et al. · 2023 · Journal of Thrombosis and Haemostasis
56. Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis
    Aaron Thomas Gerds, Claire N. Harrison, Jean‐Jacques Kiladjian, Ruben A. Mesa, Alessandro Maria Vannucchi, Rami S. Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J. Mead, Jason R. Gotlib et al. · 2024 · Blood Advances
57. A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis
    Srđan Verstovšek, Moshe Talpaz, Ellen Kelly Ritchie, Martha Wadleigh, Olatoyosi M. Odenike, Catriona H. M. Jamieson, Brady Lee Stein, Tomonori Uno, Ruben A. Mesa · 2016 · Leukemia
58. A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
    John O Mascarenhas, Lonette Sandy, Min Lü, James Yoon, Bruce E. Petersen, David Zhang, Fei Ye, Carrie Newsom, Vesna Najfeld, Tsivia Hochman et al. · 2016 · Leukemia Research
59. Clinical Significance of Isolated Myeloperoxidase Expression in Pediatric B-Lymphoblastic Leukemia
    Matthew James Oberley, Sisi Li, Etan Orgel, Choo Phei Wee, Ashley S. Hagiya, Maurice R.G. O’Gorman · 2017 · American Journal of Clinical Pathology
60. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience
    Lianna Jean Marks, Jennifer A. Oberg, Danielle Pendrick, Anthony N. Sireci, Chana L. Glasser, Carrie Coval, Rebecca J. Zylber, Wendy K. Chung, Jiuhong Pang, Andrew T. Turk et al. · 2017 · Frontiers in Pediatrics
61. The Molecular Pathology of Myelodysplastic Syndrome
    Torsten Haferlach · 2018 · Pathobiology
62. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations
    Lisa J. McReynolds, Yanqin Yang, Hong Yuen Wong, Jingrong Tang, Yubo Zhang, Matthew P. Mulè, Janine R. Daub, Cindy L. Palmer, Ladan Foruraghi, Qingguo Liu et al. · 2018 · Leukemia Research
63. Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing
    Bingqing Zhang, Jingli Gu, Junru Liu, Beihui Huang, Juan Li · 2019 · Medical Science Monitor
64. Second malignancies in multiple myeloma; emerging patterns and future directions
    Kylee H. Maclachlan, Benjamin T. Diamond, Francesco Maura, Jens Hillengaß, Ingemar Turesson, Ola Landgren, Dickran Gano Kazandjian · 2020 · Best Practice & Research Clinical Haematology
65. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
    Simone Cesaro, Marta Pillon, Martin G. Sauer, Frans J. W. Smiers, Maura Faraci, Cristina Díaz de Heredia, Robert Francis Wynn, Johann Greil, Franco Locatelli, Paul A. Veys et al. · 2020 · Bone Marrow Transplantation
66. Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group
    Stefano Giardino, Régis Peffault de Latour, Mahmoud Deeb Aljurf, Dirk‐Jan Eikema, Paul V. Bosman, Yves Bertrand, Abdelghani Tbakhi, Wolfgang Holter, Martin Bornhäuser, Claudia Rössig et al. · 2020 · American Journal of Hematology
67. Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis
    Juliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, Mohamad Jawhar, Christel Weiß, Georgia Metzgeroth, Alicia Schmid, Johannes Lübke, Lukas Reiter, Alice Charlotte Fabarius et al. · 2020 · The Journal of Allergy and Clinical Immunology In Practice
68. Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
    Yu‐Hung Wang, Chien‐Chin Lin, Chia‐Lang Hsu, Sheng‐Yu Hung, Chi‐Yuan Yao, Sze‐Hwei Lee, Cheng‐Hong Tsai, Hsin‐An Hou, Wen‐Chien Chou, Hwei‐Fang Tien · 2020 · Annals of Hematology
69. Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment
    Astrid Wintering, Christopher C. Dvorak, Elliot Stieglitz, Mignon L. Loh · 2021 · Blood Advances
70. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System
    Waters, Aubri M., Park, Hyun J., Weskamp, Andrew L., Mateja, Allyson, Kachur, Megan E., Lyons, Jonathan J., Rosen, Benjamin J., Boggs, Nathan A. · 2022 · The Journal of Allergy and Clinical Immunology In Practice
71. Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
    Hassan K. Awada, Maria Teresa Voso, Paola Guglielmelli, Carmelo Gurnari · 2020 · Cancers
72. JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
    Michael Stephan Bader, Sara C. Meyer · 2022 · Pharmaceuticals
73. Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
    Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd, Natalia Curto‐García, Parvis Sadjadian, Lee‐Yung Shih, Timothy Devos, Dorota Krochmalczyk, Serena Galli, Maria Bieniaszewska et al. · 2022 · Blood Advances
74. Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
    Guangyang Weng, Yu Zhang, Guopan Yu, Tingyue Luo, Sijian Yu, Na Xu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang et al. · 2022 · Journal of Internal Medicine
75. Overlapping features of therapy-related and de novo NPM1 -mutated AML
    Jad Othman, Manja Meggendorfer, Enrico Tiacci, Christian Thiede, Richard F. Schlenk, Richard James Dillon, Sebastian Stasik, Alessandra Venanzi, Sarah Bertoli, Éric Delabesse et al. · 2022 · Blood
76. Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome
    Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata Monika Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo et al. · 2023 · Cancer
77. Myeloid sarcoma: more and less than a distinct entity
    Giuseppe Gaetano Loscocco, Alessandro Maria Vannucchi · 2023 · Annals of Hematology
78. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
    Vincent Alcazer, Grégoire Le Meur, Marie Roccon, Sabrina Barrière, Baptiste Le Calvez, Bouchra Badaoui, Agathe Spaeth, Olivier Kosmider, Nicolas Freynet, Marion Eveillard et al. · 2024 · The Lancet Digital Health
79. Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis
    Animesh Dev Pardanani, Ramy A. Abdelrahman, Christy M. Finke, Terra L. Lasho, Kebede H. Begna, Aref Al‐Kali, William J. Hogan, Mark Robert Litzow, Curtis A. Hanson, Rhett P. Ketterling et al. · 2014 · Leukemia
80. Progress in Acute Myeloid Leukemia
    Tapan Mahendra Kadia, Farhad Ravandi, Susan Mary O'Brien, Jörge E. Cortes, Hagop M. Kantarjian · 2014 · Clinical Lymphoma Myeloma & Leukemia
81. Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
    Renata Mendes de Freitas, Carlos Magno da Costa Maranduba · 2015 · Revista Brasileira de Hematologia e Hemoterapia
82. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms
    Stephan Bartels, Elisa Schipper, Britta Hasemeier, Hans Heinrich Kreipe, Ulrich Lehmann · 2016 · Oncotarget
83. Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients
    Francesco Passamonti, Barbara Mora, Toni Giorgino A, Paola Guglielmelli, Mario Cazzola, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason R. Gotlib et al. · 2016 · Leukemia
84. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents
    Ana Alfonso Piérola, Guillermo Montalban Bravo, Koichi Takahashi, Elias Joseph Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Jörge E. Cortes, Zeev E. Estrov, Gautam M. Borthakur, Naveen Pemmaraju et al. · 2017 · American Journal of Hematology
85. Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML
    Anna Stengel, Wolfgang Kern, Manja Meggendorfer, Niroshan Nadarajah, Karolína Perglerová, Torsten Haferlach, Claudia Haferlach · 2017 · Leukemia
86. Gender and survival in essential thrombocythemia: A two‐center study of 1,494 patients
    Ayalew Tefferi, Silvia Betti, Daniela Barraco, Mythri Mudireddy, Sahrish H Shah, Curtis A. Hanson, Rhett P. Ketterling, Animesh Dev Pardanani, Naseema Gangat, Giacomo Coltro et al. · 2017 · American Journal of Hematology
87. Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes
    Valentina Giudice, Lauren Gabriele Banaszak, Fernanda Gutierrez‐Rodrigues, Sachiko Kajigaya, Reema Panjwani, Maria del Pilar Fernandez Ibanez, Olga Julia Rios, Christopher K. E. Bleck, Erin Stempinski, Diego Quinones Raffo et al. · 2018 · Haematologica
88. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
    Sanam Loghavi, Dawen Sui, Peng Wei, Guillermo Garcia‐Manero, Sherry A. Pierce, Mark J. Routbort, Elias Joseph Jabbour, Naveen Pemmaraju, Rashmi Kanagal‐Shamanna, Hatice Deniz Gur et al. · 2018 · Blood Advances
89. Countries' classification by environmental resilience
    Sanaz Moghim, Roja Kaveh Garna · 2018 · Journal of Environmental Management
90. 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
    Thomas P. J. Hofer, Arjan A. van de Loosdrecht, Christiane Stahl‐Hennig, Marco Antonio Cassatella, Loems Ziegler‐Heitbrock · 2019 · Frontiers in Immunology
91. Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients
    Abhishek Avinash Mangaonkar, David M. Swoboda, Giacomo Coltro, Terra L. Lasho, Paul J. Novotny, Prateek A. Pophali, Ryan Michael Carr, Moritz Binder, Christy M. Finke, Naseema Gangat et al. · 2019 · Leukemia
92. Acute Leukemia: Diagnosis and Treatment
    Lisa M. Blackburn, Sarah Bender, Shelly Brown · 2019 · Seminars in Oncology Nursing
93. Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Yi‐Bin Chen, Nirav Niranjan Shah, Anne S. Renteria, Corey S. Cutler, Johan P. Jansson, Mona Akbari, Chunlin Chen, Syed M S Quadri, Andrejus Parfionovas, Steven Michael Devine · 2019 · Blood Advances
94. Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation
    Giorgia Bucciol, Bethany A. Pillay, José Casas-Martín, Selket Delafontaine, Marijke Proesmans, Natalie Lorent, Johan Coolen, Thomas Tousseyn, Xavier Bossuyt, Cindy S. Ma et al. · 2020 · Journal of Clinical Immunology
95. The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles
    Elise Aasebø, Frode S. Berven, Randi Hovland, Stein Ove Døskeland, Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares · 2020 · Cancers
96. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
    Marta Magaz, Alberto Álvarez‐Larrán, Dolors Colomer, Mònica López‐Guerra, Ángeles García‐Criado, Gabriel Mezzano P., Ernest Belmonte, Pol Olivas, Guillem Soy, Francisco Cervantes et al. · 2020 · Journal of Hepatology
97. Evidence-Based Minireview: Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review
    Mrinal M. Patnaik, Terra L. Lasho · 2020 · Hematology
98. Acute lymphoid leukemia etiopathogenesis
    Thiago Cezar Fujita, Nathália Sousa-Pereira, M. K. Amarante, M. Watanabe · 2021 · Molecular Biology Reports
99. Erythroleukemia-historical perspectives and recent advances in diagnosis and management
    Boddu, Prajwal, Benton, Christopher B., Wang, Wei, Borthakur, Gautam, Khoury, Joseph D., Pemmaraju, Naveen · 2018 · Blood Reviews
100. Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing
     Elisabeth Mack, André Marquardt, Danny Langer, Petra Ross, Alfred Ultsch, Michael G Kiehl, Hildegard I. D. Mack, Torsten Haferlach, Andreas Neubauer, Cornelia A. Brendel · 2018 · Haematologica